Molecular cloning, genomic organization and recombinant expression of a crustin-like antimicrobial peptide from black

Piti Amparyup1, Hidehiro Kondo, Ikuo Hirono

  • 1National Center for Genetic Engineering and Biotechnology, National Science and Technology Development Agency, 113 Paholyothin Rd., Klong1, Klong Luang, Pathumthani 12120, Thailand.

Molecular Immunology
|September 14, 2007
PubMed

Insights

A novel antimicrobial peptide, Crus-likePm, was discovered in shrimp. This peptide effectively combats Gram-positive and Gram-negative bacteria, including Vibrio harveyi, offering potential for aquaculture disease control.

Area of Science:

  • Marine biology
  • Immunology
  • Biochemistry

Background:

  • Shrimp aquaculture faces significant losses due to bacterial pathogens like Vibrio harveyi.
  • Antimicrobial peptides (AMPs) are crucial components of innate immunity in invertebrates.
  • Understanding shrimp AMPs can lead to novel disease management strategies.

Purpose of the Study:

  • To identify and characterize a novel crustin-like antimicrobial peptide (Crus-likePm) from Penaeus monodon.
  • To investigate the gene structure, expression, and antimicrobial activity of Crus-likePm.
  • To assess the potential of Crus-likePm in combating shrimp bacterial infections.

Main Methods:

  • Identification and sequence analysis of Crus-likePm from shrimp haemocytes.
  • Phylogenetic analysis to compare Crus-likePm with other crustins.
  • Gene structure analysis, including exon-intron organization and promoter region investigation.
  • mRNA expression analysis via quantitative PCR after bacterial challenge.
  • Recombinant expression of Crus-likePm in E. coli and purification.
  • Antimicrobial activity assays against various bacterial strains.

Main Results:

  • A novel Crus-likePm was identified, featuring a glycine-rich N-terminus and a WAP domain with 12 conserved cysteines.
  • Phylogenetic analysis confirmed Crus-likePm as distinct from other known shrimp crustins.
  • The Crus-likePm gene comprises two exons and one intron, with putative transcription factor binding sites in its 5'-flanking region.
  • Crus-likePm mRNA was highly expressed in haemocytes and significantly upregulated following Vibrio harveyi infection.
  • Recombinant Crus-likePm exhibited potent antimicrobial activity against both Gram-positive and Gram-negative bacteria, including Vibrio harveyi.

Conclusions:

  • Crus-likePm is a novel antimicrobial peptide with a unique structure and significant antimicrobial properties.
  • Its expression is inducible by bacterial infection, highlighting its role in shrimp innate immunity.
  • Recombinant Crus-likePm demonstrates broad-spectrum antibacterial activity, showing promise as a therapeutic agent for shrimp aquaculture.

Related Concept Videos